<DOC>
	<DOCNO>NCT00727077</DOCNO>
	<brief_summary>The objective study assess safety efficacy Intron A ( 3 Mio I.E./m2 , 3 time per week ) Rebetol ( 15 mg/kg/day ) child age 3 17 , treat common medical practice 10 site Germany . The primary objective determine new severe adverse event observe recently approve dosing regimen . The study also evaluate rate eradication HCV virus . This study terminate due low enrollment . At time termination , 3 participant enrol . Therefore , 3 participant transfer study P04538 ( NCT00727077 ) include P04538 ( NCT00727077 ) data reporting .</brief_summary>
	<brief_title>Post-marketing Surveillance Children With Chronic Hepatitis C Treated With Intron A ( Vial Pen ) Rebetol ( Study P04397 ) ( TERMINATED )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Patients chronic hepatitis C ( serum HCVRNApositive ) Age 3 17 year Treatmentna√Øve Platelets &gt; = 100,000/mm^3 Neutrophil count &gt; = 1,500/ mm^3 TSH must within normal limit Hemoglobin &gt; =12 g/dL ( female ) ; &gt; =13 g/dL ( male ) Women childbearing potential must routine pregnancy test perform monthly treatment 7 month thereafter . Sexually active female subject childbearing potential must practice adequate contraception ( intrauterine device , oral contraceptive , implanted contraceptive , surgical sterilization , barrier method , monogamous relationship male partner vasectomy use condom ( + spermicide ) treatment period 7 month stop treatment . Sexually active male subject must practice acceptable method contraception ( vasectomy , use condom + spermicide , monogamous relationship female partner practice acceptable method contraception ) treatment period 7 month stop treatment . Contraindications accord SPC European approval Pretreatment chronic hepatitis C Liver decompensation Hypersensitivity active substance interferon excipients Pregnant woman Woman breast feed Existence history psychiatric condition , particular depression , suicidal ideation suicide attempt A history severe preexist cardiac disease , include unstable uncontrolled cardiac disease previous six month Severe debilitate medical condition , include patient chronic renal failure creatinine clearance &lt; 50 mlLmin Autoimmune hepatitis history autoimmune disease Severe hepatic dysfunction decompensated cirrhosis liver Pre exist thyroid disease unless control conventional therapy Epilepsy and/or compromise central nervous system function Individual decision physician patient suitable treatment ( e.g. , disturbance growth )</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>